The Cancer Research Institute launches a first-of-its-kind open-access database to help scientists better understand how the immune system responds to cancer treatments over time. The collaborative ...

Researchers conducted a systematic review of studies assessing the cost-effectiveness or cost-utility of adjuvant immunotherapy for treating various types of cancer.

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Very few patients developed serious side effects, the hospital said, underlining the safety of such treatment.

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...

Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new research from ...

A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...

Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...

Cervical cancer treatment evolves with molecular screening and immunotherapies, emphasizing early detection as key to ...